How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Self-service Pharmacies Market
- By Service Model: Automated Dispensing Systems, Kiosk-based Self-service, Mobile App-based Ordering, In-store Self-checkout, Telepharmacy Self-service
- By Product Category: Prescription Medications, Over-the-Counter (OTC) Drugs, Health and Wellness Products, Medical Devices and Supplies, Personal Care Products
- By End User: Retail Pharmacy Customers, Hospital Outpatients, Long-term Care Facilities, Corporate Wellness Programs, Pharmacy Chains
- By Technology Platform: RFID-enabled Dispensing, Barcode Scanning Systems, Touchscreen Interfaces, AI-powered Medication Management, Cloud-based Inventory Systems
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Automated Dispensing Systems leads By Service Model at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Self-service Pharmacies Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Service Model 5
Product Category 5
End User 5
Technology Platform 5
Companies profiled
CVS Health
Walgreens Boots Alliance
Cencora (formerly McKesson Corporation)
Rite Aid Corporation
Walmart Pharmacy
Boots UK (part of Walgreens Boots Alliance)
LloydsPharmacy (part of Celesio)
Kroger Pharmacy
Albertsons Companies Pharmacy
Shoppers Drug Mart (part of Loblaw Companies)
Walgreens
Pharmasave
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →CVS Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Walgreens Boots Alliance
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Cencora (formerly McKesson Corporation)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Rite Aid Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Walmart Pharmacy
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Boots UK (part of Walgreens Boots Alliance)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →LloydsPharmacy (part of Celesio)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Kroger Pharmacy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Albertsons Companies Pharmacy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Shoppers Drug Mart (part of Loblaw Companies)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Walgreens
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Pharmasave
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Well Pharmacy (UK)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Superdrug (part of AS Watson Group)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Morrisons Pharmacy
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,845M by 2033 · 11.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Automated Dispensing Systems42.5
- Kiosk-based Self-service16.4
- Mobile App-based Ordering21.0
- In-store Self-checkout8.3
- Telepharmacy Self-service11.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,353M → $3,233M · 11.5%
Europe$943.2M → $2,094M · 10.5%
Asia Pacific$861.2M → $2,023M · 11.3%
Latin America$533.1M → $1,285M · 11.6%
Middle East and Africa$410.1M → $1,007M · 11.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.522026
11.542027
11.552028
11.552029
11.572030
11.592031
11.602032
11.602033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- CVS Health17.6
- Walgreens Boots Alliance20.8
- Cencora (formerly McKesson Corporation)12.4
- Rite Aid Corporation5.4
- Walmart Pharmacy8.7
- Boots UK (part of Walgreens Boots Alliance)7.2
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Model21.3%
Product Category26.5%
End User28.8%
Technology Platform23.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.5
- Europe21.7
- Asia Pacific21.0
- Latin America13.3
- Middle East and Africa10.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| CVS Health | 73 | 93 | 91 | 75 | 83 | 76 | 82 |
| Walgreens Boots Alliance | 79 | 72 | 90 | 80 | 70 | 78 | 78 |
| Cencora (formerly McKesson Corporation) | 82 | 64 | 84 | 77 | 82 | 80 | 78 |
| Rite Aid Corporation | 72 | 61 | 59 | 79 | 72 | 78 | 70 |
| Walmart Pharmacy | 53 | 53 | 72 | 75 | 74 | 57 | 64 |
| Boots UK (part of Walgreens Boots Alliance) | 47 | 66 | 57 | 60 | 47 | 66 | 57 |
| LloydsPharmacy (part of Celesio) | 41 | 60 | 52 | 63 | 58 | 49 | 54 |
| Kroger Pharmacy | 36 | 43 | 59 | 57 | 41 | 52 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- CVS Health
- Walgreens Boots Alliance
- Cencora (formerly McKesson Corporation)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| CVS Health | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Walgreens Boots Alliance | ◐ | − | ✓ | ✓ | ◐ | ✓ |
| Cencora (formerly McKesson Corporation) | ✓ | − | ✓ | ◐ | ✓ | ✓ |
| Rite Aid Corporation | ◐ | ◐ | − | ◐ | ✓ | ✓ |
| Walmart Pharmacy | − | ◐ | − | ✓ | ◐ | − |
| Boots UK (part of Walgreens Boots Alliance) | ◐ | ✓ | ◐ | ◐ | − | ✓ |
| LloydsPharmacy (part of Celesio) | − | ◐ | − | − | ◐ | − |
| Kroger Pharmacy | − | − | ◐ | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1CVS Health82
2Walgreens Boots Alliance78
3Cencora (formerly McKesson Corporation)78
4Rite Aid Corporation70
5Walmart Pharmacy64
6Boots UK (part of Walgreens Boots Alliance)57
7LloydsPharmacy (part of Celesio)54
8Kroger Pharmacy48
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
CVS HealthWalgreens Boots AllianceCencora (formerly McKesson Corporation)
Challenger1
Strong scale, closing on the leaders.
Rite Aid Corporation
Contender2
Focused players with pockets of strength.
Walmart PharmacyBoots UK (part of Walgreens Boots Alliance)
Niche2
Specialists in a single segment or region.
LloydsPharmacy (part of Celesio)Kroger Pharmacy
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Model in North America, then scale across Self-service Pharmacies Market — a $346M beachhead inside a $5.44B market.
Beachhead (SOM)$346Mobtainable near-term
Serviceable (SAM)$2.12Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Automated Dispensing Systems
Best fit — highest urgency & budget in Service Model.
Economic buyer76 fit
Kiosk-based Self-service
Strong fit — clear ROI and a fast path to value.
End user65 fit
Mobile App-based Ordering
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Model in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Product Category & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel28%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Service Model leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Self-service Pharmacies Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified24%
Evaluation13%
Closed-won8%
$20.8KCAC
$74KLTV
3.5:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Self-service Pharmacies Market is a resilient opportunity — $3.23B by 2033, compounding at 5.8%.
TAM · 2025$2.05Btoday
TAM · 2033$3.23Bforecast
CAGR5.8%2027–2033
Cumulative$23.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.23BTotal addressable market
SAM$1.24BServiceable available market
SOM$216MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.8% CAGR
Demand compounds through 2033, outpacing GDP across Service Model.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Model moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.23BLarge & growingTAM by 2033 at 5.8% CAGR
$1.24BServiceable nowreachable with today’s model
$216MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.52BBear3.8% CAGR
$3.23BBase5.8% CAGR
$4.14BBull7.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Product Category optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Self-service Pharmacies Market — a $6.25B market by 2033. Plan: grow share from 8.5% to 17.0%.
Market size · 2033$6.25Btotal addressable
Market CAGR5.6%2027–2033
Target share17.0%from 8.5% today
Revenue ambition$1.06Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.5% | 17.0% | On track |
| Revenue | $516M | $1.06B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 29.3% | 44.9% | On track |
| Customer retention | 89.1% | 95.9% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Model
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Product Category capability
A defensible second engine — invest in Product Category to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Model share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Product Category
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $133M capacity & capability investment
- Greenlight bolt-on M&A in Product Category
- Authorise North America expansion plan
- Fund R&D program for Service Model leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Self-service Pharmacies Market conversation — a $3.16B market you can size, segment and defend in minutes.
Market size · 2033$3.16Btotal opportunity
Growth11.2%CAGR to 2033
Addressable buyers1,306+accounts in scope
Typical ROI5.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Model
Goal Grow share in Service Model
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.2×return on cost, year one
< 4 mopayback period
$52K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
CVS HealthWalgreens Boots AllianceCencora (formerly McKesson Corporation)Rite Aid CorporationWalmart PharmacyBoots UK (part of Walgreens Boots Alliance)LloydsPharmacy (part of Celesio)Kroger Pharmacy+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Self-service Pharmacies Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Self-service Pharmacies Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Self-service Kiosks for Healthcare Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportSelf-Service Health Check Machine Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportSelf-Seal Sterilization Pouch Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportSelf Sealing Sterilization Pouches Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportSelf-sampling Blood Collection and Storage Devices Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportSelf-righting Needle Holder Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportSelf-retaining Retractor With Blunted Ends Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportSelf-Rescuer Respirator Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportSelf-propel Wheelchair Market
Market size, share, segmentation and regional forecast.
$970M market · 2025 base year
View reportSelf-Myofascial Release Rollers Market
Market size, share, segmentation and regional forecast.
$915M market · 2025 base year
View reportSelf-Monitoring of Blood Glucose (SMBG) Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportSelf Monitoring Blood Glucose (SMBG) Device Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.